Compare NVNO & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVNO | TCBS |
|---|---|---|
| Founded | 1987 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7M | 46.3M |
| IPO Year | N/A | N/A |
| Metric | NVNO | TCBS |
|---|---|---|
| Price | $0.33 | $16.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 956.3K | 2.8K |
| Earning Date | 10-31-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $15,268,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.09 |
| Revenue Growth | N/A | ★ 54.88 |
| 52 Week Low | $0.30 | $14.90 |
| 52 Week High | $5.62 | $19.40 |
| Indicator | NVNO | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 59.10 |
| Support Level | $0.32 | $15.90 |
| Resistance Level | $0.37 | $17.00 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 6.24 | 44.00 |
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.